Some Ototoxic Drugs Destroy Cochlear Support Cells Before Damaging Sensory Hair Cells

A wide variety of ototoxic drugs are capable of damaging the sensory hair cells in the mammalian cochlea resulting in permanent hearing loss. However, the toxic properties of these drugs suggest that some could potentially damage cochlear support cells as well. To test the hypothesis, we treated postnatal day three rat cochlear cultures with toxic doses of gentamicin, cisplatin, mefloquine, and cadmium. Gentamicin primarily destroyed the hair cells and disrupted the intercellular connection with the surrounding support cells. Gentamicin-induced hair cell death was initiated through the caspase-9 intrinsic apoptotic pathway followed by activation of downstream executioner caspase-3. In contrast, cisplatin, mefloquine, and cadmium initially damaged the support cells and only later damaged the hair cells. Support cell death was initiated through the caspase-8 extrinsic apoptotic pathway followed later by downstream activation of caspase-3. Cisplatin, mefloquine, and cadmium significantly reduced the expression of actin and laminin, in the extracellular matrix, leading to significant disarray of the sensory epithelium.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:37

Enthalten in:

Neurotoxicity research - 37(2020), 3 vom: 29. März, Seite 743-752

Sprache:

Englisch

Beteiligte Personen:

Ding, Dalian [VerfasserIn]
Zhang, Jianhui [VerfasserIn]
Jiang, Haiyan [VerfasserIn]
Xuan, Weijun [VerfasserIn]
Qi, Weidong [VerfasserIn]
Salvi, Richard [VerfasserIn]

Links:

Volltext

Themen:

00BH33GNGH
Apoptosis
Cadmium
Caspase
Caspases
Cisplatin
Cochlea
EC 3.4.22.-
Gentamicins
Hair cells
Journal Article
Mefloquine
Necrosis
Ototoxicity
Q20Q21Q62J
Support cells
TML814419R

Anmerkungen:

Date Completed 04.12.2020

Date Revised 25.10.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1007/s12640-020-00170-8

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM305930273